Response of cutaneous metastatic melanoma to topical immunotherapy with diphencyprone.
Phase of Trial: Phase I/II
Latest Information Update: 21 Jun 2016
At a glance
- Drugs Diphencyprone (Primary)
- Indications Malignant melanoma
- Focus Pharmacokinetics
- 04 Mar 2013 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry record.
- 23 Jun 2009 New trial record